Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 11 | 2022 | 443 | 3.110 |
Why?
|
| Syphilis, Congenital | 6 | 2022 | 28 | 2.750 |
Why?
|
| Syphilis | 6 | 2022 | 95 | 2.660 |
Why?
|
| Placenta Accreta | 9 | 2023 | 144 | 2.650 |
Why?
|
| Ultrasonography, Prenatal | 17 | 2023 | 906 | 2.320 |
Why?
|
| Placenta Previa | 6 | 2023 | 63 | 1.380 |
Why?
|
| Pregnancy | 30 | 2023 | 7124 | 1.020 |
Why?
|
| Penicillin G Benzathine | 4 | 2022 | 18 | 0.990 |
Why?
|
| Hernia, Umbilical | 1 | 2021 | 41 | 0.710 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 85 | 0.700 |
Why?
|
| Prenatal Care | 3 | 2020 | 340 | 0.650 |
Why?
|
| Premature Birth | 1 | 2022 | 380 | 0.600 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2020 | 237 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 2397 | 0.570 |
Why?
|
| Cervical Length Measurement | 1 | 2017 | 3 | 0.570 |
Why?
|
| Cervix Uteri | 1 | 2017 | 70 | 0.550 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 111 | 0.520 |
Why?
|
| Reagins | 1 | 2014 | 3 | 0.490 |
Why?
|
| Uterine Hemorrhage | 1 | 2015 | 47 | 0.480 |
Why?
|
| Cardiolipins | 1 | 2014 | 19 | 0.480 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 41 | 0.480 |
Why?
|
| Infant, Newborn | 10 | 2023 | 8089 | 0.480 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2014 | 44 | 0.470 |
Why?
|
| Parents | 1 | 2021 | 1023 | 0.450 |
Why?
|
| Hysterectomy | 4 | 2019 | 185 | 0.420 |
Why?
|
| Prenatal Diagnosis | 4 | 2021 | 580 | 0.400 |
Why?
|
| Female | 30 | 2023 | 65423 | 0.400 |
Why?
|
| Cholesterol | 1 | 2014 | 525 | 0.390 |
Why?
|
| Gestational Age | 2 | 2017 | 1121 | 0.390 |
Why?
|
| Blood Platelet Disorders | 1 | 2011 | 13 | 0.370 |
Why?
|
| Ampicillin | 1 | 2010 | 58 | 0.360 |
Why?
|
| Fetal Death | 1 | 2011 | 113 | 0.360 |
Why?
|
| Placenta | 4 | 2023 | 493 | 0.340 |
Why?
|
| Streptococcus agalactiae | 1 | 2010 | 105 | 0.330 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 105 | 0.320 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 244 | 0.290 |
Why?
|
| Zika Virus Infection | 3 | 2019 | 165 | 0.280 |
Why?
|
| Placenta Diseases | 2 | 2018 | 57 | 0.280 |
Why?
|
| Humans | 30 | 2023 | 123177 | 0.270 |
Why?
|
| Adult | 14 | 2019 | 29033 | 0.270 |
Why?
|
| Zika Virus | 2 | 2019 | 140 | 0.260 |
Why?
|
| Retrospective Studies | 11 | 2023 | 15979 | 0.260 |
Why?
|
| Thrombosis | 1 | 2011 | 520 | 0.260 |
Why?
|
| Hepatomegaly | 2 | 2016 | 21 | 0.260 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 24 | 0.250 |
Why?
|
| Arthrogryposis | 2 | 2019 | 33 | 0.210 |
Why?
|
| Blood Loss, Surgical | 2 | 2019 | 146 | 0.190 |
Why?
|
| Postpartum Hemorrhage | 2 | 2019 | 91 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 121 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2024 | 0.180 |
Why?
|
| Cesarean Section | 3 | 2019 | 382 | 0.180 |
Why?
|
| Public Health | 1 | 2022 | 261 | 0.170 |
Why?
|
| Carpal Bones | 1 | 2019 | 6 | 0.170 |
Why?
|
| Clubfoot | 1 | 2019 | 19 | 0.170 |
Why?
|
| Ultrasonography | 3 | 2023 | 945 | 0.170 |
Why?
|
| Polydactyly | 1 | 2019 | 17 | 0.170 |
Why?
|
| Radius | 1 | 2019 | 25 | 0.170 |
Why?
|
| Chorionic Villi Sampling | 4 | 2019 | 45 | 0.170 |
Why?
|
| Thumb | 1 | 2019 | 29 | 0.170 |
Why?
|
| Truth Disclosure | 1 | 2021 | 103 | 0.170 |
Why?
|
| Amniocentesis | 4 | 2019 | 76 | 0.170 |
Why?
|
| Patient Care Team | 3 | 2019 | 547 | 0.170 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 254 | 0.160 |
Why?
|
| Extremities | 1 | 2019 | 82 | 0.160 |
Why?
|
| Microarray Analysis | 4 | 2019 | 231 | 0.160 |
Why?
|
| Penicillins | 1 | 2019 | 154 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 120 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2019 | 4708 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 148 | 0.140 |
Why?
|
| Polyhydramnios | 1 | 2016 | 55 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2016 | 75 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 53 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 87 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 62 | 0.130 |
Why?
|
| United States | 2 | 2022 | 10618 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 134 | 0.130 |
Why?
|
| Trophoblasts | 1 | 2017 | 112 | 0.130 |
Why?
|
| Prognosis | 4 | 2019 | 4508 | 0.130 |
Why?
|
| Global Health | 1 | 2020 | 557 | 0.130 |
Why?
|
| Cesarean Section, Repeat | 1 | 2015 | 6 | 0.120 |
Why?
|
| Hepatitis E virus | 1 | 2014 | 4 | 0.120 |
Why?
|
| Hepatitis Delta Virus | 1 | 2014 | 6 | 0.120 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2014 | 9 | 0.120 |
Why?
|
| Watchful Waiting | 1 | 2015 | 63 | 0.120 |
Why?
|
| Blood Volume | 1 | 2015 | 80 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3518 | 0.120 |
Why?
|
| Pregnancy, High-Risk | 1 | 2014 | 46 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2014 | 57 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 108 | 0.120 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1871 | 0.110 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2838 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 192 | 0.110 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 137 | 0.110 |
Why?
|
| Logistic Models | 2 | 2018 | 1799 | 0.110 |
Why?
|
| Infant | 2 | 2022 | 12321 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 594 | 0.110 |
Why?
|
| Young Adult | 4 | 2019 | 8866 | 0.110 |
Why?
|
| Virus Replication | 1 | 2017 | 604 | 0.110 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 197 | 0.110 |
Why?
|
| Genetic Testing | 4 | 2019 | 997 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2014 | 241 | 0.110 |
Why?
|
| ROC Curve | 1 | 2014 | 557 | 0.100 |
Why?
|
| Viral Load | 1 | 2014 | 382 | 0.100 |
Why?
|
| Anemia | 1 | 2016 | 339 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 730 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12102 | 0.100 |
Why?
|
| Delphi Technique | 1 | 2023 | 200 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 280 | 0.100 |
Why?
|
| Dilatation and Curettage | 1 | 2011 | 6 | 0.090 |
Why?
|
| Embolectomy | 1 | 2011 | 9 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 47 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 120 | 0.090 |
Why?
|
| Thrombophilia | 1 | 2011 | 40 | 0.090 |
Why?
|
| Abdomen | 1 | 2011 | 130 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2851 | 0.090 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 62 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 12 | 0.090 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 30 | 0.090 |
Why?
|
| Leg | 1 | 2011 | 154 | 0.090 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 18 | 0.090 |
Why?
|
| Algorithms | 1 | 2016 | 1597 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2108 | 0.080 |
Why?
|
| Encephalocele | 2 | 2019 | 50 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 117 | 0.080 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 84 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 180 | 0.080 |
Why?
|
| Prevalence | 1 | 2014 | 2403 | 0.070 |
Why?
|
| Fever | 1 | 2010 | 296 | 0.070 |
Why?
|
| Risk Factors | 3 | 2019 | 10001 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 596 | 0.070 |
Why?
|
| Incidence | 1 | 2015 | 3050 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3007 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 359 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2011 | 585 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 3332 | 0.060 |
Why?
|
| Microcephaly | 2 | 2019 | 328 | 0.060 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 5 | 0.040 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 8 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 13 | 0.040 |
Why?
|
| Breech Presentation | 1 | 2019 | 21 | 0.040 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 43 | 0.040 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 29 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 44 | 0.040 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 62 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 90 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 46 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 79 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 158 | 0.040 |
Why?
|
| New Orleans | 1 | 2019 | 13 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2019 | 53 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 53 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 21 | 0.040 |
Why?
|
| South America | 1 | 2019 | 38 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 67 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 15 | 0.040 |
Why?
|
| Spine | 1 | 2019 | 143 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2019 | 165 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 294 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 96 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 98 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 121 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 178 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 58 | 0.040 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 145 | 0.040 |
Why?
|
| Trachea | 1 | 2019 | 202 | 0.040 |
Why?
|
| Esophagus | 1 | 2019 | 213 | 0.040 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1802 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 229 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 309 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 35 | 0.040 |
Why?
|
| Giant Cells | 1 | 2017 | 34 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2019 | 280 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 84 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2017 | 104 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1114 | 0.030 |
Why?
|
| Dengue | 1 | 2017 | 110 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 124 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2019 | 426 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 533 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 336 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1684 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 685 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2017 | 540 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 391 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 964 | 0.030 |
Why?
|
| Kidney | 1 | 2019 | 1338 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3260 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 25973 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3050 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3548 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 831 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6028 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4225 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2947 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 19084 | 0.010 |
Why?
|